Abstract
Background
For over 20 years, researchers wanting to record, discuss and compare drug-related problems (DRPs) have had the task of choosing between a multiplicity of classification systems offering a variable number of categories identified as causes of DRPs and DRPs.
Objective
To characterise studies which have reported DRPs through the use of a DRP classification system to determine types of classification systems chosen, factors influencing their choice, and methodological issues that may have affected their application.
Method
A systematic search of MEDLINE, CINAHL, International Pharmaceutical Abstracts (Ovid), EMBASE and PubMed was performed. All English language studies reporting DRPs through the use of a classification system published between January 2000 and July 2013 were reviewed, with no limitation on the type of study.
Results
Of 2,774 articles screened, 268 met our inclusion criteria. We identified the use of 20 different types of DRP classification systems. Three quarters of studies modified an existing classification system or developed their own. Few studies stated reasons for choice of system. We identified issues such as variability in skills of data collectors, selective choice of patients and missing data, affecting application of classification systems and limiting quality, analysis and comparison of studies.
Conclusion
There appeared to be no consensus on preference or structure of classification systems. Future studies should consider addressing or acknowledging the methodological issues identified. Through identification and discussion of these problems, recommendations for future studies and for practice have been made.
Similar content being viewed by others
References
Hepler CD, Strand LM (1990) Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 47:533–543
Van Mil JWF, Westerlund T, Hersberger T, Schaefer MA (2004) Drug-related problem classification systems. Ann Pharmacother 38:859–867
Comite de Consenso (2007) Third consensus of Grenada on drug related problems (DRP) and negative outcomes associated with medicines http://farmacia.ugr.es/ars/pdf/374.pdf Accessed 5 March 2014
Fernandez-Llamazares CM, Manrique-Rodriguez S, Perez-Sanz C, Duran-Garcia ME, Sanjurjo-Saez M, Calleja-Hernandez MA (2012) Validation of a method for recording pharmaceutical interventions. J Clin Pharm Ther 37:459–463
Cipolle RJ, Strand LM, Morley PC (1998) Pharmaceutical care practice. McGraw-Hill, New York
Baena MI, Faus MJ, Fajardo PC, Luque FM, Sierra F, Martinez-Olmos J, Cabrera A, Fernandez-Llimos F, Martinez-Martinez F, Jimenez J, Zarzuelo A (2006) Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol 62:387–393
Bondesson A, Eriksson T, Kragh A, Holmdahl L, Midlov P, Hoglund P (2013) In-hospital medication reviews reduce unidentified drug-related problems. Eur J Clin Pharmacol 69:647–655
Gomez MA, Villafaina A, Hernandez J, Salgado RM, Gonzalez MA, Rodriguez J, de la Concha MM, Tarrino A, Gervasini G, Carrillo JA (2009) Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting. Ann Pharmacother 43:339–346
Krska J, Jamieson D, Arris F, McGuire AJ, Abbott S, Hansford D, Cromarty JA (2002) A classification system for issues identified in pharmaceutical care practice. Int J Pharm Pract 10:91–100
Lampert ML, Kraehenbuehl S, Hug BL (2008) Drug-related problems: evaluation of a classification system in the daily practice of a Swiss university hospital. Pharm World Sci 30:768–776
MacKinnon NJ, Morais CL, Rose T (2007) Drug-related problems identified in a workplace asthma self-management program. Can Pharm J 140:110–115
Vinks THAM, de Koning FHP, de Lange TM, Egberts TCG (2006) Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci 28:33–38
Ruths S, Viktil KK, Blix HS (2007) Classification of drug-related problems. Tidsskr Nor Laegeforen 127:3073–3076
AbuRuz SM, Bulatova NR, Yousef AM (2006) Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci 28:222–232
Al-Arifi M, Abu-Hashem H, Al-Meziny M, Said R, Aljadhey H (2013) Emergency department visits and admissions due to drug related problems at Riyadh military hospital (RMH), Saudi Arabia. Saudi Med J. doi:10.1016/j.jsps.2013.01.001
Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R (2012) Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm 34:828–831
Leendertse AJ, de Koning FHP, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Egberts ACG, van den Bemt PMLA (2013) Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther 38:379–387
Nicolas A, Eickhoff C, Griese N, Schulz M (2013) Drug-related problems in prescribed medicines in Germany at the time of dispensing. Int J Clin Pharm 35:476–482
Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H (2004) Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci 26:353–360
Williams M, Peterson GM, Tenni PC, Bindoff IK, Curtain C, Hughes J, Bereznicki LRE, Jackson SL, Kong DCM, Hughes JD (2011) Drug-related problems detected in Australian Community Pharmacies: The PROMISe trial. Ann Pharmacother 45:1067–1076
Young SW, Bishop LD, Conway A (2012) Interventions performed by community pharmacists in one Canadian province: a cross-sectional study. Ther Clin Risk Manag 8:415–421
Farrell B, Szeto W, Shamji S (2011) Drug-related problems in the frail elderly. Can Fam Physician 57:168–169
Halvorsen KH, Ruths S, Granas AG, Viktil KK (2010) Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care 28:82–88
Huri HZ, Wee HF (2013) Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study. www.biomedcentral.com/1472-6823/13/2. BMC Endocrine Disorders 13:1–12
Chan D-C, Chen J-H, Kuo H-K, We C-J, Lu I-S, Chiu L-S, Wu S-C (2012) Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr 54:168–174
Christensen AB, Holmbjer L, Midlov P, Hoglund P, Larsson L, Bondesson A, Eriksson T (2011) The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm 33:1010–1018
Eichenberger PM, Lampert ML, Kahmann IV, van Mil JWF, Hersberger KE (2010) Classification of drug-related problems with new prescriptions using a modified PCNE classification system. Pharm World Sci 33:362–372
Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC (2012) DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm 34:43–52
Gordon KJ, Smith FJ, Dhillon S (2005) The development and validation of a screening tool for the identification of patients experiencing medication-related problems. Int J Pharm Pract 13:187–193
Haley M, Raymond C, Nishi C, Bohm E (2009) Drug-related problems in patients undergoing elective total joint arthroplasty of the hip or knee. Can J Hosp Pharm 62:360–366
Hammerlein A, Griese N, Schulz M (2007) Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 41:1825–1832
Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C (2006) Implementation of ward-based clinical pharmacy services in Belgium—description of the impact on a geriatric unit. Ann Pharmacother 40:720–728
Zargarzadeh AH, Emami MH, Hosseini F (2007) Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol 34:494–498
Bjorkman IK, Bernsten CB, Sanner MA (2008) Care ideologies reflected in 4 conceptions of pharmaceutical care. Res Soc Adm Pharm 4:332–342
Bjorkman IK, Sanner MA, Bernsten CB (2008) Comparing 4 classification systems for drug-related problems: processes and functions. Res Soc Adm Pharm 4:320–331
Crisp GD, Burkhart JI, Esserman DA, Weinberger M, Roth MT (2011) Development and testing of a tool for assessing and resolving medication-related problems in older adults in an ambulatory care setting: the individualised medication assessment and planning (iMAP) tool. Am J Geriatr Pharmacother 9(6):451–460
Fernandez-Llimos F, Tuneu L, Baena MI, Garcia-Delgado A, Faus MJ (2004) Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems. Curr Pharm Des 10:3947–3967
Pharmaceutical Care Network Europe Foundation (2010) Classification for drug related problems V6.2 http://www.pcne.org/sig/drp/documents/PCNE%20classification%20V6-2.pdf. Accessed 10 Jan 2014
Cipolle RJ, Strand LM, Morley PC (2012) Pharmaceutical care practice: the patient centered approach to medication management Services, 3rd edn. McGraw-Hill, New York
Westerlund TLO, Bjork HT (2006) Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother 40:1162–1169
Burns A (2008) Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 48:341–353
Pharmaceutical Society of Australia (2011) Guidelines for pharmacists providing Home Medicines Review (HMR) services 2011 http://www.psa.org.au/download/practice-guidelines/home-medicines-review-services.pdf. Accessed 3 March 2014
Peterson G, Tenni PC, Bereznicki L, Hughes J, Kong D, Doran C, Williams M, Curtain C, Hughes J, Ellerton L, Bindoff I (2010) PROMISe III: Documenting clinical interventions in community pharmacy. http://guild.org.au/services-programs/research-and-development/archive---fourth-agreement/2007-08-09. Accessed 28 Jan 2014
Taylor G (2013) SHPA standards of practice for clinical pharmacy services. Society of Hospital Pharmacists of Australia. J Pharm Pract Res 43:S1–S62
Dutch College of General Practitioners (2012) Multidisciplinary directive polypharmacy in the elderly https://www.nhg.org/themas/artikelen/mdr-polyfarmacie-bij-ouderen. Accessed 3 Mar 2014
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
Sollaci LB, Periera MG (2004) The introduction, methods, results, and discussion (IMRAD) structure: a fifty-year survey. J Med Libr Assoc 92:364–371
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163(22):2716–2724
National Health and Medical Research Council (2000) How to use the evidence: assessment and application of scientific evidence. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp69.pdf. Accessed 3 Mar 2014
AbuRuz SM, Bulatova NR, Yousef AM, Al-Ghazawi AM, Alawwa IA, Al-Saleh A (2011) Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan. Int J Clin Pharm 33:501–511
Andersson AC, Brodin H, Nilsson JLG (2003) Pharmacist interventions in relation to patient drug-related problems. J Soc Adm Pharm 20:82–91
Barnett MJ, Frank J, Wehring H, Newland B, VonMuenster S, Kumbera P, Halterman T, Perry PJ (2009) Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 15:18–31
Bedouch P, Allenet B, Grass A, Labarere J, Brudieu E, Bosson J-L, Calop J (2009) Drug-related problems in medical wards with a computerised physician order entry system. J Clin Pharm Ther 34:187–195
Bergqvist M, Ulfvarson J, Karlsson EA, Von Bahr C (2008) A nurse-led intervention for identification of drug-related problems. Eur J Clin Pharmacol 64:451–456
Blakey SA, Hixson-Wallace JA (2000) Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic. Pharmacotherapy 20:1198–1203
Bulsink A, Imholz ALT, Brouwers JRBJ, Jansman FGA (2013) Characteristics of potential drug-related problems among oncology patients. Int J Clin Pharm 35:401–407
Dhabali AAH, Awang R, Hamdan Z, Zyoud SH (2012) Association between the prescribing of non-steroidal anti-inflammatory drugs and the potential prescription-related problems in a primary care setting. Int J Clin Pharmacol Ther 50:851–861
Emmerton L, Shaw J, Kheir N (2003) Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther 28:395–402
Fejzic JB, Tett SE (2004) Medication management reviews for people from the former Yugoslavia now resident in Australia. Pharm World Sci 26:271–276
Hall DL, Pater KS (2011) Implementation of a medication therapy management program in a hospital-based outpatient pharmacy. Hosp Pharm 46:512–518
Kassam R, Farris KB, Burback L, Volume CI, Cox CE, Cave A (2001) Pharmaceutical care research and education project: pharmacists’ interventions. J Am Pharm Assoc 41:401–410
Krass I, Smith C (2000) Impact of medication regimen reviews performed by community pharmacists for ambulatory patients through liaison with general medical practitioners. Int J Pharm Pract 8:111–120
Krska J, Avery AJ (2007) Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol 65(3):386–396
McDonough RP, Doucette WR (2003) Drug therapy management: an empirical report of drug therapy problems, pharmacists’ interventions, and results of pharmacists’ actions. J Am Pharm Assoc 43:511–518
Midlov P, Bondesson A, Eriksson T, Petersson J, Minthon L, Hoglund P (2002) Descriptive study and pharmacotherapeutic intervention in patients with epilepsy or Parkinson’s disease at nursing homes in southern Sweden. Eur J Clin Pharmacol 57:903–910
Roth MT, Esserman DA, Ivey JL, Weinberger M (2009) Racial disparities in the quality of medication use in older adults: baseline findings from a longitudinal study. J Gen Intern Med 25:228–234
Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P (2006) Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci 28:61–64
Westberg SM, Sorensen TD (2005) Pharmacy-related health disparities experienced by non-English-speaking patients: impact of pharmaceutical care. J Am Pharm Assoc 45:48–54
Al-Olah YH, Al Thiab KM (2008) Admissions through the emergency department due to drug-related problems. Ann Saudi Med 28426–429
Bladh L, Ottosson E, Karlsson J, Klintberg L, Wallerstedt SM (2011) Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial. BMJ Qual Saf 20:738–746
Blix HS, Viktil KK, Moger TA, Reikvam A (2006) Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci 28:152–158
Khdour MR, Jarab AS, Adas HO, Samaro EZ, Mukattash TL, Hallak HO (2012) Identification of drug-related problems: a prospective study in two general hospitals. Curr Clin Pharmacol 7:276–281
Krahenbuhl J-M, Decollogny A, Bugnon O (2008) Using the costs of drug therapy to screen patients for a community pharmacy-based medication review program. Pharm World Sci 30:816–822
Krahenbuhl J-M, Kremer B, Guignard B, Bugnon O (2008) Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci 30:777–786
Laaksonen R, Duggan C, Bates I (2010) Performance of community pharmacists in providing clinical medication reviews. Ann Pharmacother 44:1181–1190
Leikola S, Virolainen J, Tuomainen L, Tuominen RK, Airaksinen MSA (2012) Comprehensive medication reviews for elderly patients: findings and recommendations to physicians. J Am Pharm Assoc 52:630–633
Patel HR, Pruchnicki MC, Hall LE (2005) Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacother 39:22–27
Ruths S, Straand J, Nygaard HA (2003) Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen district nursing home (BEDNURS) study. Qual Saf Health Care 12:176–180
Somers A, Robays H, Vander Stichele R, Van Maele G, Bogaert M, Petrovic M (2010) Contribution of drug related problems to hospital admission in the elderly. J Nutr Health Aging 14:477–482
van Roozendaal BW, Krass I (2009) Development of an evidence-based checklist for the detection of drug related problems in type 2 diabetes. Pharm World Sci 31:580–595
Vinks THAM, Egberts TCG, de Lange TM, de Koning FHP (2009) Pharmacist-based medication review reduces potential drug-related problems in the elderly. Drugs Aging 26:123–133
Finkers F, Maring JG, Boersma F, Taxis K (2007) A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther 32:469–476
Puts MTE, Cosat-Lima B, Monette J, Girre V, Wolfson C, Batist G, Bergman H (2009) Medication problems in older, newly diagnosed cancer patients in Canada: how common are they? A prospective pilot study. Drugs Aging 26:519–536
Puts MTE, Monette J, Girre V, Cosat-Lima B, Wolfson C, Batist G, Bergman H (2010) Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment. Drugs Aging 27:559–572
Stafford L, Stafford A, Hughes J, Angley M, Bereznicki L, Peterson G (2011) Drug-related problems identified in post-discharge medication reviews for patients taking warfarin. Int J Clin Pharm 33:612–626
Stuijt CCM, Franssen EJF, Egberts ACG, Hudson SA (2008) Appropriateness of prescribing among elderly patients in a Dutch residential home. Drugs Aging 25:947–954
Taegtmeyer AB, Curkovic I, Rufibach K, Corti N, Battegay E, Kullak-Ublick GA (2011) Electronic prescribing increases uptake of clinical pharmacologists’ recommendations in the hospital setting. Br J Clin Pharmacol 72:958–964
Titley-Lake C, Barber N (2000) Drug-related problems in the elders of the British Virgin Islands. Int J Pharm Pract 8:53–59
Koh Y, Kutty FBM, Li SC (2003) Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study. Pharm World Sci 25:135–137
Koh Y, Kutty FBM, Li SC (2005) Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag 1:39–48
Kwint H-F, Faber A, Gussekloo J, Bouvy ML (2011) Effects of medication review on drug-related problems in patients using automated drug-dispensing systems. Drugs Aging 28(4):305–314
Moczygemba LR, Barner JC, Gabrillo ER (2012) Outcomes of a medicare part D telephone medication therapy management program. J Am Pharm Assoc 52:e144–e152
Montgomery AT, Kalvemark-Sporrong S, Tully P, Kettis-Lindblad A (2008) Follow-up of patients receiving a pharmaceutical care service in Sweden. J Clin Pharm Ther 33:653–662
Ong SW, Fernandes OA, Cesta A, Bajcar JM (2006) Drug-related problems on hospital admission: relationship to medication information transfer. Ann Pharmacother 40:408–413
Langebrake C, Hilgarth H (2010) Clinical pharmacists’ interventions in a German university hospital. Pharm World Sci 32:194–199
Raybardhan S, Balen RM, Partovi N, Loewen PS, Liu G, Jewesson PJ (2005) Documenting drug-related problems with personal digital assistants in a multisite health system. Am J Health Syst Pharm 62:1782–1787
Rogers K, Tierney M, Singh A, McLean W (2003) Assessment of a seamless care prescription/discharge notes form. Can J Hosp Pharm 56:14–23
Roth MT, Ivey JL, Esserman DA, Crisp G, Kurz J, Weinberger M (2013) Individualised medication assessment and planning: optimizing medication use in older adults in the primary care setting. Pharmacotherapy 33:787–797
Roughead EE, Barratt JD, Gilbert AL (2004) Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiol Drug Saf 13:83–87
Scott DM, Dewey MW, Johnson TA, Kessler ML, Friesner DL (2010) Preliminary evaluation of medication therapy management services in assisted living facilities in rural Minnesota. Consult Pharm 25:305–319
Sorensen L, Stokes JA, Purdie DM, Woodward MC, Elliott RA, Roberts MS (2004) Medication reviews in the community: results of a randomised, controlled effectiveness trial. Br J Clin Pharmacol 58(6):648–664
Sturgess IK, McElnay JC, Hughes CM, Crealey G (2003) Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 25:218–226
Vink J, Morton D, Ferreri S (2011) Pharmacist identification of medication-related problems in the home care setting. Consult Pharm 26:477–484
Westerlund LOT, Marklund BRG, Handl WHA, Thunberg ME, Allebeck P (2001) Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 35:1343–1349
Hata M, Klotz R, Sylvies R, Hess K, Schwartzmann E, Scott J, Law AV (2012) Medication therapy management services provided by student pharmacists. Am J Pharm Educ 76 Article 51:1–6
Hooper R, Adam A, Kheir N (2009) Pharmacist-documented interventions during the dispensing process in a primary health care facility in Qatar. Drug Health Patient Saf 1:73–80
Becker C, Bjornson DC, Kuhle JW (2004) Pharmacist care plans and documentation of follow-up before the Iowa pharmaceutical case management program. J Am Pharm Assoc 44:350–357
Stafford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, Rasmussen M (2009) Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci 31:216–223
Tenni P, Stafford A, Peterson G, Jackson SL (2007) A comparison of drug related problems identified in RMMRs and HMRs. Aust Pharm 26:414–420
Haugbolle LS, Sorensen EW (2006) Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma—interviewing patients at home. Pharm World Sci 28:239–247
Kaur S, Roberts JA, Roberts MS (2012) Evaluation of medication-related problems in medication reviews: a comparative perspective. Ann Pharmacother 46:972–982
Zaal RJ, Jansen MMPM, Duisenberg-van Essenberg M, Tijssen CC, Roukema JA, Van Den Bemt PMLA (2013) Identification of drug-related problems by a clinical pharmacist in addition to computerised alerts. Int J Clin Pharm 35:753–762
Garcao JA, Cabrita J (2002) Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc 42:858–864
Nurgat ZA, Al-Jazairi AS, Abu-Shraie N, Al-Jedai A (2011) Documenting clinical pharmacist intervention before and after the introduction of a web-based tool. Int J Clin Pharm 33:200–207
Eichenberger PM, Haschke M, Lampert ML, Hersberger KE (2011) Drug-related problems in diabetes and transplant patients: an observational study with home visits. Int J Clin Pharm 33:815–823
Ax F, Branstad J-O, Westerlund T (2010) Pharmacy counselling models: a means to improve drug use. J Clin Pharm Ther 35:439–451
Eickhoff C, Hammerlein A, Griese N, Schulz M (2012) Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf 21:254–260
Basheti IA, Qunaibi EA, Bulatova NR, Samara S, AbuRuz S (2013) Treatment related problems for outpatients with chronic diseases in Jordan: the value of home medication reviews. Int J Clin Pharm 35:92–100
Singh H, Kumar BN, Sinha T, Dulhani N (2011) The incidence and nature of drug-related hospital admission: a 6-month observational study in a tertiary health care hospital. J Pharmacol Pharmacother 2:17–20
Van Mil JWF, Dudok van Heel MC, Boersma M, Tromp FJ (2001) Interventions and documentation for drug-related problems in Dutch community pharmacies. Am J Healt Syst Pharm 58:1428–1431
Granas AG, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix HS, Kilhovd B, Viktil KK, Horn AM (2010) Evaluating categorisation and clinical relevance of drug-related problems in medication reviews. Pharm World Sci 32:394–403
Ellis SL, Billups SJ, Malone DC, Carter BL, Covey D, Mason B, Jue S, Carmichael J, Guthrie K, Sintek CD, Dombrowski R, Geraets DR, Amato M (2000) Types of interventions made by clinical pharmacists in the IMPROVE study. Pharmacotherapy 20:429–435
Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, Kettis-Lindblad A, Melhus H, Morlin C (2009) A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch Intern Med 169:894–900
Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA (2003) Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 163:1813–1820
Isetts BJ, Schondelmeyer SW, Artz MB, Lenarz LA, Heaton AH, Wadd WB, Brown LM, Cipolle RJ (2008) Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc 48:203–211
LaFleur J, McBeth C, Gunning K, Oberda L, Steinvoort C, Oberda GM (2006) Prevalence of drug-related problems and cost-savings opportunities in Medicaid high utilizers identified by a pharmacist-run drug regimen review center. J Manag Care Pharm 12:677–685
Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H (2009) Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomised, controlled study. Pharmacotherapy 29:1433–1440
Shimp LA, Kucukarslan SN, Elder J, Remington T, Wells T, Choe HM, Lewis NJW, Kirking DM (2012) Employer-based patient-centered medication therapy management program: evidence and recommendations for future programs. J Am Pharm Assoc 52(768–776)
Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD (2002) Collaborative medication management services: improving patient care. Med J Aust 177:189–192
Kwint H-F, Gussekloo J, Bouvy ML (2012) The contribution of patient interviews to the identification of drug-related problems in home medication review. J Clin Pharm Ther 37:674–680
Naunton M, Peterson GM (2003) Evaluation of home-based follow-up of high-risk elderly patients discharged from hospital. J Pharm Pract Res 33:176–182
Stemer G, Laml-Wallner G, Kuegler I, Poelzleitner P, Messner S, Steininger S, Dolinar E, Zehetmayer S (2012) Comprehensive evaluation of clinical pharmacists’ interventions in a large Austrian tertiary care hospital. Eur J Hosp Pharm 19:529–534
Alderman CP, Farmer C (2001) A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract 21:99–103
Al-Hajje AH, Atoui F, Awada S, Rachidi S, Zein S, Salameh P (2012) Drug-related problems identified by clinical pharmacist’s students and pharmacist’s interventions. Ann Pharm Fr 70:169–176
Bednall R, McRobbie D, Hicks A (2003) Identification of medication-related attendances at an A and E department. J Clin Pharm Ther 28:41–45
Bedouch P, Charpiat B, Conort O, Rose F-X, Escofier L, Juste M, Roubille R, Allenet B (2008) Assessment of clinical pharmacists’ interventions in French hospitals: results of a multicenter study. Ann Pharmacother 42:1095–1103
Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF (2006) Drug-related problems in the community setting: pharmacists’ findings and recommendations for people with mental illnesses. Clin Drug Investig 26(7):415–425
Blix HS, Viktil KK, Reikvam A, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK (2004) The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 60:651–658
Bourne RS, Dorward BJ (2011) Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation. Int J Clin Pharm 33:755–758
Castelino RL, Bajorek BV, Chen TF (2011) Are interventions recommended by pharmacists during Home Medicines Review evidence-based? J Eval Clin Pract 17:104–110
Castro I, Guardiola JM, Tuneu L, Sala ML, Faus MJ, Mangues MA (2013) Drug-related visits to the emergency department in a Spanish university hospital. Int J Clin Pharm 35:727–735
Christensen DB, Roth MT, Trygstad T, Byrd J (2007) Evaluation of a pilot medication therapy management project within the North Carolina state health plan. J Am Pharm Assoc 47:471–483
Davidsson M, Vibe OE, Ruths S, Blix HS (2011) A multidisciplinary approach to improve drug therapy in nursing homes. J Multidiscip Healthc 4:9–13
de Oliveira DR, Brummel AR, Miller DB (2010) Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 16:185–195
Ellitt GR, Engblom E, Aslani P, Westerlund T, Chen TF (2010) Drug related problems after discharge from an Australian teaching hospital. Pharm World Sci 32:622–630
Farris KB, Ganther-Urmie JM, Fang G, Doucette WR, Brooks JM, Klepser DG, Fries DJ, Kuhle CL (2004) Population-based medication reviews: a descriptive analysis of the medication issues identified in a Medicare not-for-profit prescription discount program. Ann Pharmacother 38:1823–1829
Freeman CR, Cottrell WN, Kyle G, Williams ID, Nissen L (2013) An evaluation of medication review reports across different settings. Int J Clin Pharm 35:5–13
Hugtenburg JG, Blom ATG, Gopie CTW, Beckeringh JJ (2004) Communicating with patients the second time they present their prescription at the pharmacy. Pharm World Sci 2004(26):328–332
Lee J, McPherson ML (2006) Outcomes of recommendations by hospice pharmacists. Am J Health Syst Pharm 63:2235–2239
Lewinski D, Wind S, Belgardt C, Plate V, Behles C, Schweim HG (2010) Prevalence and safety-relevance of drug-related problems in German community pharmacies. Pharmacoepidemiol Drug Saf 19:141–149
Lopez MAP, Saliente MTA, Company ES, Monsalve AG, Cueva MA, Domingo EA, Hernandez MM, Carrion CC, Marti MC, Querejeta NB, Blasco JB, Mila AR (2010) Drug-related problems at discharge: results on the Spanish pharmacy discharge programme CONSULTENOS. Int J Pharm Pract 18:297–304
Manley HJ, Drayer DK, McClaran M, Bender W, Muther RS (2003) Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy 23:231–239
Manley HJ, McClaran ML, Overbay DK, Wright MA, Reid GM, Bender WL, Neufeld TK, Hebbar S, Muther RS (2003) Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 41:386–393
Manley HJ, Drayer DK, Muther RS (2003) Medication-related problem type and appearance rate in ambulatory hemodialysis patients. BMC Nephrology 4:http://www.biomedcentral.com/1471-2369/1474/1410
Mannheimer B, Ulfvarson J, Eklof S, Bergqvist M, Andersen-Karlsson E, Pettersson H, von Bahr C (2006) Drug-related problems and pharmacotherapeutic advisory intervention at a medicine clinic. Eur J Clin Pharmacol 62:1075–1081
Maxwell K, Harrison J, Scahill S, Braund R (2013) Identifying drug-related problems during transition between secondary and primary care in New Zealand. Int J Pharm Pract 21:333–336
Milos V, Rekman E, Bondesson A, Eriksson T, Jakobsson U, Westerlund T, Midlov P (2013) Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled trial. Drugs Aging 30:235–246
Pai AB, Boyd A, Chavez A, Manley HJ (2009) Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: a 2-year randomised, controlled study. Hemodial Int 13:72–79
Parthasarathi G, Ramesh M, Kumar JK, Madaki S (2003) Assessment of drug-related problems and clinical pharmacists’ interventions in an Indian teaching hospital. J Pharm Pract Res 33:272–274
Rao D, Gilbert AL, Strand LM, Cipolle RJ (2007) Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci 29:647–654
Repp KL, Hayes C, Woods M, Allen KB, Kennedy K, Borkon MA (2012) Drug-related problems and hospital admissions in cardiac transplant recipients. Ann Pharmacother 46:1299–1307
Sellors J, Kaczorowski J, Sellors C, Dolovich L, Woodward C, Willan A, Goeree R, Cosby R, Trim K, Sebalt R, Howard M, Hardcastle L, Poston J (2003) A randomised controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 169:17–22
Taegtmeyer AB, Curkovic I, Corti N, Rosen A, Egbring M, Russmann S, Gantenbein AR, Weller M, Kullak-Ublick GA (2012) Drug-related problems and factors influencing acceptance of clinical pharmacologists’ alerts in a large cohort of neurology inpatients. Swiss Med Wkly 142:w13615
Touchette DR, Massica AL, Dolor RJ, Schumock GT, Choi YK, Kinm Y, Smith SR (2012) Safety-focused medication therapy management: a randomized controlled trial. J Am Pharm Assoc 52:603–612
Viktil KK, Blix HS, Reikvam A, Moger TA, Hjemaas BJ, Walseth EK, Vraalsen TF, Pretsch P, Jorgensen F (2004) Comparison of drug-related problems in different patient groups. Ann Pharmacother 38:942–948
Viktil KK, Blix HS, Moger TA, Reikvam A (2006) Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf 15:667–674
Westerlund T, Gelin U, Pettersson E, Skarlund F, Wagstrom K, Ringbom C (2013) A retrospective analysis of drug-related problems documented in a national database. Int J Clin Pharm 35:202–209
Schaefer M (2002) Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 24:120–127
Brulhart MI, Wermeille JP (2011) Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm 33:549–557
Joseph J, Ramesh M, Harugeri A, Parthasarathi G, Basavanagowdappa H (2010) Frequency and nature of medication-related problems in elderly Indian inpatients. J Pharm Pract Res 40:279–283
Elliott RA, Martinac G, Campbell S, Thorn J, Woodward MC (2012) Pharmacist-led medication review to identify medication-related problems in older people referred to an aged care assessment team. A randomized comparative study. Drugs Aging 29(7):593–605
Easton KL, Chapman CB, Brien JE (2004) Frequency and characteristics of hospital admissions associated with drug-related problems in paediatrics. Br J Clin Pharmacol 57:611–615
Gisev N, Bell JS, O'Reilly CL, Rosen A, Chen TF (2010) An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. Soc Psychiatr Epidemiol 45:1071–1079
Ernst ME, Doucette WR, Dedhiya SD, Osterhaus MC, Kumbera PA, Osterhaus JT, Townsend RJ (2001) Use of point-of-sale health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders. Pharmacotherapy 21:988–997
Ulfvarson J, Rahmner PB, Fastbom J, Sjoviker S, Karlsson EA (2010) Medication reviews with computerised expert support. Evaluation of a method to improve the quality of drug utilisation in the elderly. Int J Health Care Qual Assur 23:571–582
Bergqvist M, Ulfvarson J, Karlsson EA (2009) Nurse-led medication reviews and the quality of drug treatment of elderly hospitalized patients. Eur J Clin Pharmacol 65:1089–1096
Celin AT, Seuma J, Ramesh A (2012) Assessment of drug-related problems in stroke patients admitted to a South Indian tertiary care teaching hospital. Ind J Pharm Pract 5:28–33
Charpiat B, Goutelle S, Schoeffler M, Aubrun F, Viale J-P, Ducerf C, Leboucher G, Allenet B (2012) Prescriptions analysis by clinical pharmacists in the post-operative period: a 4-year prospective study. Acta Anaesthesiol Scand 56:1047–1051
Delate T, Chester EA, Stubbings TW, Barnes CA (2008) Clinical outcomes of a home-based medication reconciliation program after discharge from a skilled nursing facility. Pharmacotherapy 28:444–452
Doucette WR, McDonough RP, Klepser D, McCarthy R (2005) Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther 27:1104–1111
Martinez-Lopez I, Do-Pazo-Oubina F, Lozano-Vilardell P (2011) Comprehensive pharmaceutical care in a vascular surgery department. Farm Hosp 35:260–263
Prot-Labarthe S, Di Paolo ER, Lavoie A, Quennery S, Bussieres J-F, Brion F, Bourdon O (2013) Pediatric drug-related problems: a multicenter study in four French-speaking countries. Int J Clin Pharm 35:251–259
Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW (2006) Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 166:565–571
Triller DM, Clause SL, Briceland LL, Hamilton RA (2003) Resolution of drug-related problems in home care patients through a pharmacy referral service. Am J Health Syst Pharm 60:905–910
Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D (2000) Providing pharmaceutical care using a systematic approach. Pharm J 265:656–660
Wermeille J, Bennie M, Brown I, McKnight J (2004) Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team—a pilot study. Pharm World Sci 26:18–25
Vercaigne LM, Grymonpre RE, Metge C, Sekyere J, Cooper R (2000) Manitoba pharmaceutical care project; interim report. Can Pharm J 133:1–7
Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA, Bayes-Genis A (2011) Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Cardiac Fail 17:217–223
Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD (1990) Drug-related problems: their structure and function. Drug Intell Clin Pharm (Ann Pharmacother) 24:1093–1097
Castelino RL, Sathvik BS, Parthasarathi G, Gurudev KC, Shetty MS, Narahari MG (2011) Prevalence of medication-related problems among patients with renal compromise in an Indian hospital. J Clin Pharm Ther 36:481–487
Rossing C, Hansen EH, Krass I, Traulsen JM (2003) Pharmaceutical care in Denmark: perceived importance of medicine-related problems and participation in postgraduate training. Pharm World Sci 25:73–78
Nickel CH, Ruedinger JM, Messmer AS, Maile S, Peng A, Bodmer M, Kressig RW, Kraehenbuehl S, Bingisser R (2013) Drug-related emergency department visits by elderly patients presenting with non-specific complaints. http://www.sjtrem.com/content/21/1/15 SJTREM 21:1–9
Chan D-C, Chen J-H, Wen C-J, Chiu L-S, Wu S-C (2012) Effectiveness of the medication safety review clinics for older adults prescribed multiple medications. J Formos Med Assoc. doi:10.1016/j.jfma.2012.04.013
Smith M, Giuliano MR, Starkowski MP (2011) In Connecticut: improving patient medication management in primary care. Health Aff 30:646–654
Rogers S, Wilson DA, Wan S, Griffin M, Rai G, Farrell J (2009) Medication-related admissions in older people. A cross-sectional, observational study. Drugs Aging 26:951–961
de Oliveira MPF, Novaes MRCG (2011) Drug-related problems in institutionalised elderly in Brasilia, Brazil. Biomed Aging Pathol 1:179–184
Viktil KK, Blix HS, Moger TA, Reikvam A (2006) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63:187–195
Zed PJ, Riyad B, Abu-Laban RB, Balen RM, Loewen PS, Hohl CM, Brubacher JR, Wilbur K, Weins MO, Samoy LJ, Lacaria K, Purssell RA (2008) Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ 178:1563–1569
Westerlund T, Marklund B (2009) Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther 34:319–327
Willoch K, Blix HS, Pederson-Bjergaard AM, Eek AK, Reikvam A (2012) Handling drug-related problems in rehabilitation patients: a randomized study. Int J Clin Pharm 34:382–388
Pintor-Marmol A, Baena MI, Fajardo PC, Sabater-Hernandez D, Saez-Benito L, Garcia-Cardenas MV, Fikri-Benbrahim N, Azpilicueta I, Faus MJ (2012) Terms used in patient safety related to medication: a literature review. Pharmacoepidemiol Drug Saf 21:799–809
Fernandez-Llimos F, Faus MJ (2005) From “drug-related problems” to “negative clinical outcomes”. Am J Health Syst Pharm 62:2348–2350
Andreazza RS, De Castro MS, Koche PS, Heineck I (2011) Causes of drug-related problems in the emergency room of a hospital in southern Brazil. Gac Sanit 25:501–506
Hatah E, Tordoff J, Duffull SB, Braund R (2014) Pharmacists’ performance of clinical interventions during adherence support medication reviews. RSAP 10:185–194
Villa LA, Von Chrismar AM, Oyarzun C, Eujenin P, Fernandez ME, Quezada M (2009) Pharmaceutical care program for dyslipidemic patients at three primary health care centers: impacts and outcomes. Lat Am J Pharm 28:415–420
Rashed AS, Neubert A, Alhamdan H, Tomlin S, Alazmi A, Al Shaikh A, Wilton L, Wong ICK (2013) Drug-related problems found in children attending an emergency department in Saudi Arabia and in the United Kingdom. Int J Clin Pharm 35:327–331
Cipolle RJ, Strand LM, Morley PC (2004) Pharmaceutical care practice: the clinician’s guide 2nd edition. McGraw-Hill
Al-Jazairi AS, Al-Agil AA, Asiri YA, Al-kholi TA, Akhras NS, Horanieh BK (2008) The impact of clinical pharmacist in a cardiac-surgery intensive care unit. Saudi Med J 29:277–281
de Almeida NY, da Silva CW, de Assis AF (2009) Drug-related problems observed in a pharmaceutical care service, Belo Horizonte, Brazil. Braz J Pharm Sci 45:321–330
Krska J, Ross SM, Watts M (2005) Medication reviews provided by general medical practitioners (GPs) and nurses: an evaluation of their quality. Int J Pharm Pract 13:77–84
Mirkov SR, Ball PA (2003) Design and pilot of a medication review clinic in a dialysis centre. J Pharm Pract Res 33:199–203
Gisev N, Bell JS, Chen TF (2013) Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Soc Adm Pharm 9:330–338
Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B, Juste M, Conort O (2006) Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci 28:181–188
Tujn S, Janssens F, Robben P, van den Bergh H (2012) Reducing interrater variability and improving health care: a meta-analytical review. J Eval Clin Pract 18:887–895
Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F (2013) A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother 47:946–952
Conflict of interest
All authors declare that we have no conflict of interest. The manuscript does not contain clinical studies or patient data, for which consent or ethical permission was required.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Basger, B.J., Moles, R.J. & Chen, T.F. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol 70, 799–815 (2014). https://doi.org/10.1007/s00228-014-1686-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-014-1686-x